Picture of Orgenesis logo

ORGS — Orgenesis News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Orgenesis Inc expected to post a loss of 3 cents a share - Earnings Preview

* Orgenesis Inc  ORGS.OQ   ORGS.O  is expected to show a rise in
quarterly revenue when it reports  results on November 3
(estimated). 
* The Germantown, Maryland-based company is expected to report 
a 420.5% increase in revenue to $9 million from $1.73 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
​* Refinitiv's mean analyst estimate for Orgenesis Inc is for a
loss of 3 cents per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Orgenesis Inc
is $9​, about 46.6% above​ its last closing price of $4.81. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   -0.23       -0.23      -0.11     Beat    52.2
 Mar. 312021   -0.26       -0.26      0.01      Beat    103.8
                                                        ​
 ​​                                                     
 Mar. 312020               -0.20      -0.39     Missed  -95​
 Dec. 312019               -0.27      -0.42     Missed  -55.6
 Sep. 302019   -0.28       -0.28      -0.44     Missed  -57.1
 This summary was machine generated November 1 at 18:32 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Orgenesis

See all news